LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Banglun Pan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Proto-Oncogene Proteins c-akt, Receptors, Immunologic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Joint Funds for the Innovation of Science and Technology, Fujian Province, High-level medical care construction foundation of Fujian province.
Abstract (Originalsprache)
LAIR1, a receptor found on immune cells, is capable of binding to collagen and is involved in immune‐related diseases. However, the precise contribution of LAIR1 expressed on hepatocellular carcinoma (HCC) cells to tumor microenvironment is still unclear. In our study, bioinformatics analysis and immunofluorescence were employed to study the correlation between LAIR1 levels and clinical indicators. Transwell and scratch tests were used to evaluate how LAIR1 affected the migration and invasion of HCC cells. The chemotactic capacity and alternative activation of macrophages were investigated using RT‐qPCR, transwell, and immunofluorescence. To investigate the molecular mechanisms, transcriptome sequencing analysis, Western blot, nucleus/cytoplasm fractionation, ELISA, and cytokine microarray were employed. We revealed a significant correlation between the presence of LAIR1 and an unfavorable outcome in HCC. We indicated that LAIR1 promoted migration and invasion of HCC cells through the AKT‐IKKβ‐p65 axis. Additionally, the alternative activation and infiltration of tumor‐associated macrophages induced by LAIR1 were reliant on the upregulation of IL6 and CCL5 within this axis, respectively. In conclusion, blocking LAIR1 was found to be an effective approach in combating the cancerous advancement of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Laboratory Medicine, Fujian Medical University Union Hospital, Fuzhou, China.
- Cancer Center of Fujian Medical University, Fujian Medical University Union Hospital, Fuzhou, China.
- Key Laboratory of Clinical Laboratory Technology for Precision Medicine (Fujian Medical University), Fujian Province University, Fuzhou, China.
ORCID-Profile: Nanhong Tang
Förderung
- Natural Science Foundation of Fujian Province
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- High-level medical care construction foundation of Fujian province
Zitieren
APA
Pan, B., Shen, S., Zhao, J., Zhang, Z., Ye, D., Zhang, X., Yao, Y., Luo, Y., Wang, X., & Tang, N. (2024). LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23776
Vancouver
Pan B, Shen S, Zhao J, Zhang Z, Ye D, Zhang X, et al. LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23776
BibTeX
@article{Pan2024,
author = {Pan, Banglun and Shen, Shuling and Zhao, Jun and Zhang, Zhu and Ye, Dongjie and Zhang, Xiaoxia and Yao, Yuxin and Luo, Yue and Wang, Xiaoqian and Tang, Nanhong},
title = {LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23776}
}
EUVIMED